E2 ModeratePreliminaryPEM unclearCase-ControlPeer-reviewedMachine draft
Reduced levels of oestrogen receptor beta mRNA in Swedish patients with chronic fatigue syndrome.
Gräns, Hanna, Nilsson, Maria, Dahlman-Wright, Karin et al. · Journal of clinical pathology · 2007 · DOI
Quick Summary
This study looked at a protein called estrogen receptor beta in immune cells from ME/CFS patients and healthy people. Researchers found that ME/CFS patients had lower levels of this protein compared to healthy controls. Since estrogen plays a role in immune function and ME/CFS affects more women than men, this finding suggests hormone-related immune problems might be involved in the disease.
Why It Matters
This study is important because it provides a potential biological mechanism linking the sex bias observed in ME/CFS (more prevalent in women) to dysfunctional estrogen signaling in immune cells. Identifying decreased estrogen receptor expression offers a testable hypothesis for understanding immune dysregulation in ME/CFS and could guide future therapeutic investigations.
Observed Findings
- CFS patients showed significantly lower mRNA expression levels of estrogen receptor beta wild-type (ERbeta wt) compared to healthy controls
- No significant differences were observed in estrogen receptor alpha (ERalpha) mRNA expression between CFS patients and controls
- No significant differences were observed in estrogen receptor beta cx (ERbeta cx) mRNA expression between patients and controls
- Two investigated estrogen receptor beta SNPs showed no significant differences in frequency between CFS patients and healthy controls
Inferred Conclusions
- Reduced ERbeta wt expression in CFS is consistent with an immune-mediated pathogenesis of the disease
- Estrogen receptor beta may be involved in disease mechanisms in ME/CFS
- Further investigation of the connection between estrogen, estrogen receptors, and CFS is warranted
Remaining Questions
- Is the reduced ERbeta wt expression a cause or consequence of ME/CFS?
- What functional consequences does reduced estrogen receptor beta expression have on immune cell function in ME/CFS patients?
- Do sex differences in hormone levels and receptor expression explain the female predominance of ME/CFS?
What This Study Does Not Prove
This study does not prove that reduced estrogen receptor beta causes ME/CFS, only that an association exists. The study cannot establish whether the reduced expression is a cause or consequence of the disease. The findings are correlational and would need functional studies and replication in larger, more diverse populations before clinical implications can be determined.
Tags
Symptom:Fatigue
Biomarker:Gene ExpressionBlood Biomarker
Method Flag:Weak Case DefinitionSmall SampleExploratory Only
Metadata
- DOI
- 10.1136/jcp.2005.035956
- PMID
- 16731592
- Review status
- Machine draft
- Evidence level
- Single-study or moderate support from human research
- Last updated
- 8 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →